RARE vs TARA · rev $350.0M vs $228.8M cap
Ultragenyx (RARE) versus Protara Therapeutics Inc (TARA) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Protara Therapeutics Inc (TARA) is a biotechnology company listed on NASDAQ.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
TARA does not have a complete income-statement cache yet.
RARE currently screens at market cap $2.79B. TARA currently screens at market cap $228.8M.
Not investment advice. Open the RARE and TARA stock pages for the full models.
Not investment advice.